

**----- Start of picture text -----**<br>
Trustees’ Annual Report for the period<br>Period start date Period end date<br>Day Month Year Day  Month Year<br>From 23 June 2020 To 22 June 2021<br>**----- End of picture text -----**<br>



**----- Start of picture text -----**<br>
Charity name Action Radiotherapy - ACORRN<br>Other names charity is known  ACORRN<br>by<br>Charity registration number 1135902<br>**----- End of picture text -----**<br>


## **Objectives and Activities** 


**----- Start of picture text -----**<br>
SORP reference<br>Summary of the  Para 1.17 1. To promote, support and encourage<br>purposes of the  research into radiotherapy, radiobiology<br>charity as set out in  and allied subjects, and the<br>dissemination of the useful results of<br>its governing<br>such research by such actions as:<br>document<br>a. Promoting and facilitating multidisciplinary<br>collaboration between researchers and<br>practitioners in radiotherapy and its allied<br>subjects<br>b. Informing patients and the public about<br>practice and research in radiotherapy and<br>its allied subjects, and engaging patients<br>and the public in the development of<br>research projects<br>c. Awarding grants as appropriate<br>2. To advance and benefit the practice of<br>radiotherapy and its allied subjects to<br>relieve sickness and preserve good<br>health by such actions as:<br>a. Promoting and facilitating multidisciplinary<br>networking and sharing of expertise and<br>best practice<br>b. Promoting and encouraging the study of<br>the science and practice of radiotherapy<br>and its allied subjects<br>c. Promoting and facilitating increased<br>involvement of allied professions<br>d. Facilitating development and<br>dissemination of best practices in<br>**----- End of picture text -----**<br>





**----- Start of picture text -----**<br>
radiotherapy and its allied subjects<br>e. Disseminating knowledge concerning all<br>aspects of the science and practice of<br>radiotherapy and its allied subjects<br>f. Promoting and facilitating education and<br>training in the research and practice of<br>radiotherapy and its allied subjects<br>Summary of the main  Para 1.17 and  1. Continuing development of the Action<br>1.19<br>activities in relation to Radiotherapy website.<br>those purposes for the The current site continues to serve its purpose of<br>public benefit, in  being a resource for radiotherapy patients and<br>particular, the  those working in the profession. We have further<br>activities, projects or  developed it this year particularly adding<br>services identified in  information about the APPG for Radiotherapy and<br>the accounts.<br>patient support/advocacy work with our<br>campaigns. However, as the charity has<br>developed, and technology moves forward we<br>believe the current site is no longer fit for purpose<br>as the charity’s front of house. We recognise the<br>need for a more up to date, professional site to<br>provide current information to patients,<br>professionals, industry and interested parties. To<br>enable the hosting of webinars and podcasts and<br>provide a more streamlined journey that is easier<br>to navigate. We are seeking input on what is<br>needed and plan to outsource a redesign.<br>2. Radiotherapy4Life (Professional’s<br>campaign) and #Catchup with cancer<br>(patient campaign)<br>Action Radiotherapy is proud to be the chosen<br>charity partner of Radiotherapy4Life which has<br>continued again this year. We help support<br>Radiotherapy4Life’s campaigns by providing<br>administrative and research support. We have<br>conducted surveys and data analysis to<br>determine the current issues faced by front-line<br>staff. Our front-line staff Champion’s Network and<br>industry network hold regular meetings with the<br>Radiotherapy4Life team, providing radiotherapy<br>intelligence, sharing experience and suggesting<br>vendor neutral solutions.<br>In July 2021 in response to patient’s needs we co-<br>founded the #CatchUpWithCancer campaign<br>#Catchup With Cancer. This a is a patient<br>campaign that aims to highlight the COVID-19<br>induced cancer backlog and seeks to proposed<br>realistic solutions to the backlog. This campaign<br>has continued this year and the charity provide<br>support for patients and interpretation of<br>research.<br>3.  Further development of Champions Network<br>Our Champion’s Network is an active network of<br>**----- End of picture text -----**<br>





**----- Start of picture text -----**<br>
radiotherapy professionals who offer frontline<br>insights, mutual support, education and research<br>sharing.<br>We promote radiotherapy careers through<br>collating open radiotherapy job listings on the<br>Daily News and to the Action Radiotherapy<br>website.<br>4.General fundraising/events<br>The charity has continued to receive donations<br>via JustGiving and DonorBox from privately<br>organised fundraising events. There are 3 regular<br>donors who give in total £45 per month via a<br>recurring payment. In total we have raised<br>£10,258.76 (up from £9,464 (minus £216<br>JustGiving costs). We have continued to utilise<br>Facebook Fundraisers (£145) – where users create<br>fundraisers on their birthday to a chosen charity.<br>Similarly, we have signed up to Amazon Smile<br>(£53.51) and receive a percentage of the users’<br>spend. We were unable to undertake our usual<br>“ Running for Radiotherapy ” July event due to<br>Covid restrictions and so instead a team of<br>professionals and industry ran virtual races on x3<br>successive weekends with high social media<br>communication. Running for radiotherapy July<br>2020 This was both good for morale and mental<br>health of the profession but also raised funding.<br>5.  Our response to Covid-19<br>The charity, at beginning of the pandemic,<br>committed to providing support for those in the<br>radiotherapy profession<br>and patients receiving radiotherapy. This<br>continued in 2021. The radiotherapy workforce is<br>technology based and so electronic and social<br>media communications have been utilised for<br>rapid dissemination of information and collection<br>of feedback and concerns. When Covid-19 hit we<br>worked incredibly hard to collect and share up to<br>date resources and guidelines via social media for<br>healthcare professionals and are continuing to do<br>this. Our engagement rate increased during this<br>time meaning more people were picking up our<br>social media posts. This underlines that we are<br>seen as a reliable and current information source<br>and that our posts stand out. This is particularly<br>impressive given the amount of “noise” on social<br>media, especially during the pandemic.<br>The Action Radiotherapy Champions Network<br>devised online tools and information to assist<br>therapy radiographers in dealing with their<br>changing roles at the height of the Covid-19<br>**----- End of picture text -----**<br>





**----- Start of picture text -----**<br>
pandemic. We provided a wide variety of online<br>resources to help safeguard a person’s wellbeing<br>and that of their colleagues. The resources<br>included tips for approaching self-care including<br>a number of positive coping strategies<br>individuals could adopt within their Radiotherapy<br>department and at home. We provided a daily<br>update on publications about the COVID-19<br>pandemic and its effects on cancer patients and<br>services and in radiotherapy in particular.<br>6. Action Radiotherapy secretariat to APPG<br>Action Radiotherapy continues to act as<br>secretariat to the All-Party Parliamentary Group<br>for radiotherapy (APPG-RT).<br>The group aims to be the voice in Parliament of<br>cancer patients, their families and of those who<br>work within the radiotherapy field. The APPG now<br>has  45  (up  from  38  the  previous  year)<br>members/officers from various political<br>parties/House of Lords.<br>Recent publications by the APPGRT can be found<br>here.<br>7. Media relations<br>The #CatchUpWithCancer campaign has have<br>had almost weekly press coverage including BBC<br>breakfast, Sky news, ITV news and all major print<br>publications, and is now a major campaign in the<br>UK.<br>More information can be found here<br>8.  Expanded and enhanced communication<br>channels<br>Our media channels are a very strong aspect of<br>our work and profile and we are well respected in<br>our reach and content .<br>(i) Daily News:  This again has performed<br>strongly with Daily News subscribers<br>having increased from 1,315 to 1,466 this<br>year.<br>(ii) Twitter:   The AR Twitter feed continues to<br>grow, and the number of followers has<br>increased to 4,773, up from 3,910 a year<br>ago.<br>(iii) Facebook:  The Facebook page followers<br>have regularly increased and as of June<br>2021 stand at 1,735. (2020 = 1584)<br>(iv) Instagram:  Our following sits at 1,224<br>compared to 364 in 2020. We now have a<br>dedicated Champion volunteer who<br>oversees the charity’s account and has<br>developed a patient advocacy group<br>currently feeding into the new website re-<br>design from a patient’s perspective.<br>**----- End of picture text -----**<br>





**----- Start of picture text -----**<br>
(v) Media references:  This year there has<br>been increased media coverage of the lack<br>of radiotherapy funding in the UK due to<br>the effects of COVID-19 highlighting the<br>lack of utilisation and investment in the<br>treatment as well as the lack of patient<br>knowledge as to what radiotherapy can<br>achieve. To support AR and R4Ls media<br>work we continue to work with the press<br>offices for the Royal College of Radiologists<br>and the offices of Tim Farron MP.<br>10.  Patient Advocacy Group<br>We have a group of patients that are engaged<br>and support the charity and its work. We are in<br>regular contact via social media with the group<br>communicating on the needs of the patient and<br>helping us to raise awareness of the importance<br>of radiotherapy. Currently the Advocacy Group is<br>assisting the charity with the new website build<br>from a patient’s perspective. This is an area for<br>growth, and we plan to create a suite of resource<br>available on the new website for patients to<br>access which will explain their treatment and<br>provide additional information to help them on<br>the road to recovery.<br>Statement confirming  Para 1.18 Action Radiotherapy has had regard to the<br>whether the trustees  guidance issued by the Charity Commission on<br>public benefit.<br>have had regard to<br>the guidance issued<br>Action Radiotherapy is committed to making<br>by the Charity<br>available to the public, information regarding<br>Commission on public<br>radiotherapy treatment and its benefits, providing<br>benefit<br>opportunities for radiotherapy professionals to<br>share information as well as campaign for better<br>funding for radiotherapy treatment in the UK.<br>**----- End of picture text -----**<br>


## **Additional information (optional)** 

You may choose to include further statements where relevant about: 


**----- Start of picture text -----**<br>
SORP reference<br>Policy on grant making We do not currently have the funds to offer grants<br>however we will continue to review this.<br>Para 1.38<br>Policy on social  We will continue to respond to those wishing to<br>investment including  Para 1.38 take part in running or cycling events while<br>program related  raising awareness for Action Radiotherapy.<br>investment Whether individuals or teams of runners take part<br>we support them by providing Action<br>Radiotherapy, a JustGiving page to collect<br>donations and any advice they need from running<br>tips to fundraising.<br>**----- End of picture text -----**<br>





**----- Start of picture text -----**<br>
Contribution made by  The Champions Network member currently runs<br>volunteers Para 1.38 the Charity’s social media Instagram account and<br>patient advocacy group on a voluntary basis.<br>Other<br>**----- End of picture text -----**<br>


## **Achievements and Performance** 


**----- Start of picture text -----**<br>
SORP reference<br>Summary of the main  As well as the activities noted above, the charity<br>achievements of the  has achieved the following this year for the<br>charity, identifying the  benefit of patients, professionals, and the wider<br>difference the charity’s  Para 1.20 community:<br>work has made to the<br>circumstances of its  1. We supported the APPG for Radiotherapy in<br>beneficiaries and any<br>arranging a cancer summit of professionals<br>wider benefits to society  and MPs to look for solutions to the Covid<br>as a whole.<br>induced cancer crisis and in particular the<br>radiotherapy solutions available. A document<br>was sent to the Secretary of State for Health<br>and Social care. Cancer Summit May 2021<br>2. We undertook a Flash Survey of professionals<br>to understand the disruption that Covid-19<br>and the recovery were causing the front-line<br>radiotherapy workforce - 229 responses in<br>May 2021. The results were shared with the<br>professionals and APPG -RT to explain what<br>was needed for front line staff one year on<br>form the start of Covid AR Flash Survey May<br>2021<br>3. We coordinated a letter signed by 243<br>radiotherapy professionals to the Government<br>last year on 3 June 2020 resulted in a<br>response from the cancer minister in<br>September 2020 Reply from Jo Churchill MP,<br>cancer minister at DHSC agreeing to the<br>accelerated rollout for (SABR) to April 2021<br>backed by £14M funding. This will allow<br>around 3,000 extra patients to be treated with<br>advanced radiotherapy and increase the<br>number of patients cured.<br>4. We held a virtual world cancer day event on 4<br>February 2021 World Cancer Day 2021<br>Radiotherapy4Life. 2075 supporters emailed<br>their MPs to ask them to attend. 34<br>parliamentarians attended and 75 signed a<br>cross party letter explaining why more<br>investment was needed in radiotherapy to<br>help catch up with the cancer backlog. 16,000<br>people viewed the video we prepared for the<br>**----- End of picture text -----**<br>





**----- Start of picture text -----**<br>
event.<br>5. We held a webinar on ‘Late Effects’ on 19<br>November 2020 linking patients and<br>professionals that has been viewed by over<br>500 people on the website and supports the<br>case for referral clinics for cancer survivors<br>with late effects from pelvic radiotherapy.<br>Webinar<br>6. The Charity featured on Panorama: Britain’s<br>Cancer Crisis 6 July 2020 Panorama | Action<br>Radiotherapy. We provided real time<br>information and support to patients and<br>explained the issues around radiotherapy and<br>the Covid pandemic. This led to the setting up<br>of the #catchup with cancer campaign which<br>has supported patients and professionals with<br>information and research and advocacy.<br>**----- End of picture text -----**<br>


## **Additional information (optional)** 


**----- Start of picture text -----**<br>
You may choose to include further statements where relevant about:<br>Achievements against  N/A<br>Para 1.41<br>objectives set<br>N/A<br>Performance of<br>fundraising activities  Para 1.41<br>against objectives set<br>Other Corporate Partnerships<br>Varian: Action Radiotherapy continues to send<br>out a daily radiotherapy news bulletin every<br>Other continued weekday morning kindly sponsored by Varian<br>since October 2017.<br>**----- End of picture text -----**<br>


## **Financial Review** 

Review of the charity’s Para 1.21 The Charity, over the last 12 months, has financial position at the employed x3 experts on a part-time, freelance end of the period basis to help with managing the professional network and social media/communications. The Charity received a significant increase in 




**----- Start of picture text -----**<br>
funding this financial year due to the campaigns<br>we ran, and ended the year with £98,662.60 in<br>hand. There are plans to use the additional<br>income to appoint dedicated resources going<br>forward and to undertake a website re-launch.<br>During 2020/2021 The Charity has managed to<br>continue its work within its limited budget by<br>using its contacts and generous donations in kind<br>(resources) from Price Jones Ltd.<br>The Charity is confident that fundraising can be<br>increased through corporate and public<br>fundraising in 2021/2022 now as it has<br>significantly increased its profile due to additional<br>activities and campaigning.<br>Statement explaining the Para 1.22 The Charity assesses its financial income at the<br>policy for holding  beginning of each financial year and only plans to<br>reserves stating why they spend on regular activities within its annual<br>are held budget. The charity has no employees but pays<br>for assistance as required and within the annual<br>budget. Additional funds raised are used to<br>support specific new projects which are only<br>started when funds are in place. The Trustees<br>ensure that The Charity does not risk running into<br>debt other than noted above or develop cash flow<br>problems. The charity’s strategic spending plans<br>are flexible and can be adapted for any level of<br>charitable income.<br>Amount of reserves held Para 1.22 -£99,212.31 (excluding the related party loan<br>mentioned below)<br>Reasons for holding zero  Para 1.22 n/a<br>reserves<br>Details of fund materially Para 1.24 The Charity has a long-term interest-free loan<br>in deficit from related party Price Jones Ltd which is<br>repayable at £2,500pa. The balance at June 2021<br>is £22,672.00.<br>Explanation of any  Para 1.23 There are no current uncertainties regarding the<br>uncertainties about the  charity continuing as a going concern.<br>charity continuing as a<br>going concern<br>**----- End of picture text -----**<br>


## **Additional information (optional)** 


**----- Start of picture text -----**<br>
You may choose to include further statements where relevant about:<br>The charity’s principal  The Charity’s main source of funds for this<br>sources of funds  Para 1.47 reporting period were:<br>(including any  1. Public Donations via JustGiving, direct<br>donations and running for radiotherapy<br>fundraising)<br>fundraising events (to raise awareness)<br>2. We have received generous corporate<br>donations from: Varian Medical Systems,<br>Viewray, Elekta & Brainlab.<br>3. Radiotherapy4Life has been a major source of<br>donations this year to assist Action<br>Radiotherapy running the Radiotherpay4Life<br>campaign 2019-2021, having donated<br>£61,680.<br>Investment policy and  Para 1.46 We do not currently hold enough reserves to<br>objectives including any  warrant an investment policy.<br>social investment policy<br>adopted<br>**----- End of picture text -----**<br>




||A description of the<br>principal risks facing the<br>charity|Para 1.46|**Current Challenges**<br>1.<br>Restructuring of operations now The Charity is<br>larger to streamline responsibility and<br>delegate authority and engagement of<br>individuals to contribute to The Charity at all<br>levels.<br>2.<br>Aligned to the restructure, dedicated staf will<br>be recruited to work on The Charity and so to<br>help it grow going forward.<br>3.<br>To consider attracting Trustees from the<br>Business world<br>4.<br>Fundraising post Covid-19.<br>5.<br>Meeting current need/expectation without<br>having the necessary funding.||
|---|---|---|---|---|





## **Future initiatives** 

## Other 

The following are considered to be priorities for the coming year: 

1. Review and update the structure of The Charity as it grows and seek additional Trustees 

2. Create an Advisory Board comprised of professionals and patients 

3. Appoint dedicated resources to run The Charity 

4. Develop and implement a plan to generate more recurring funds 

5. Update our website and have clear associated messaging and branding. 

6. Develop a roadmap for this year for cancer events that we want to actively be involved in 

7. Expand our social media reach 

8. Mature the support and resources we can offer patients 

## **Structure, Governance and Management** 


**----- Start of picture text -----**<br>
Description of<br>charity’s trusts:<br>Type of governing  Para 1.25 Constitution<br>document<br>(trust deed, royal<br>charter)<br>How is the charity  Para 1.25 Association<br>constituted?<br>(e.g. unincorporated<br>association, CIO)<br>Trustee selection  Para 1.25 Original Trustees were nominated and elected<br>methods including  by the ACORRN Scientific Steering Committee.<br>details of any  New Trustees are nominated by the same<br>constitutional  process and are elected by consensus of the<br>Board of Trustees.<br>provisions e.g.<br>election to post or<br>name of any person or<br>body entitled to<br>appoint one or more<br>trustees<br>**----- End of picture text -----**<br>


## **Additional information (optional)** 

## You may choose to include further statements where relevant about: 

The Action Radiotherapy - ACORRN Constitution has two byelaws determining the charity’s **Policies and** financial and banking procedures. These Para 1.51 byelaws have been agreed by the Board of **procedures adopted** Trustees. Action Radiotherapy - ACORRN is the **for the induction and** charity which supports the activities of the **training of trustees** existing Academic Clinical Oncology and Radiobiology Research Network (ACORRN). This is a national radiotherapy research network 




**----- Start of picture text -----**<br>
which supports UK radiotherapy research and<br>development<br>within the NHS. The day-to-day management of<br>the business of the charity is the responsibility<br>of the Board of Trustees (see above).<br>The charity’s  Strategic management of the research network<br>organisational  as a mechanism to deliver The Charity’s<br>structure and any  objectives is the responsibility of the ACORRN<br>wider network with  Para 1.51 Trustees.<br>which the charity<br>works<br>Action Radiotherapy - ACORRN works closely<br>with other radiotherapy stakeholders to further<br>Relationship with any  Para 1.51 the development and delivery of radiotherapy.<br>Partner organisations (e.g. professional colleges,<br>related parties<br>charities and scientific organisations) are<br>represented on the Scientific Committee and<br>therefore input into Action Radiotherapy –<br>ACORRN’s strategies.<br>The Board of Trustees do not consider there to<br>Other be any major risks associated with The Charity<br>and its actions. The Charity assesses its financial<br>income at the beginning of each year and only<br>plans to spend on regular activities within its<br>annual budget. The Charity only has minimal<br>long-standing financial commitments and pays<br>for assistance (staff) as required and within the<br>annual budget. Additional funds raised are used<br>to support specific new projects which are only<br>started when funds are in place. The Trustees<br>ensure that The Charity does not risk running<br>into debt or develop cash flow problems. The<br>Charity’s strategic spending<br>plans are flexible and can be adapted for any<br>level of charitable income. Therefore, lower than<br>expected income would not cut short or<br>otherwise adversely affect Action Radiotherapy -<br>ACORRN’s charitable activities. If required in the<br>future, the Board of Trustees will develop<br>mechanisms for risk analysis and mitigation.<br>**----- End of picture text -----**<br>




## **Reference and Administrative details** 

Charity name Action Radiotherapy - ACORRN Other name the charity ACORRN uses Registered charity 1135902 number Charity’s principal 4 Abbotsbury House address 139 Abbotsbury Road London W14 8EN 

## **Names of the charity trustees who manage the charity** 


**----- Start of picture text -----**<br>
Dates acted if Name of person (or<br>Trustee name Office (if any) not for whole  body) entitled to appoint<br>year trustee (if any)<br>Professor Patricia  Chair Board of Trustees<br>1<br>Price<br>2 Dr Christy Goldsmith Secretary Board of Trustees<br>3 Ms Tanya Levine Treasurer Board of Trustees<br>Dr Clive Harmer Medical  Board of Trustees<br>4<br>Advisor<br>Professor Philip  Medical  Board of Trustees<br>5<br>Mayles Advisor<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>**----- End of picture text -----**<br>


Corporate trustees – names of the directors at the date the report was approved **Director name** 

Name of trustees holding title to property belonging to the charity 

**Trustee name Dates acted if not for whole year** 



## **Funds held as custodian trustees on behalf of others** 

Description of the assets None held in this capacity Name and objects of the None charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements None for safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

**Type of adviser Name Address** 

**Name of chief executive or names of senior staff members (Optional information)** 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

## **Other optional information** 



## **Declarations** 


**----- Start of picture text -----**<br>
              The trustees declare that they have approved the trustees’ report<br>above.<br>              Signed on behalf of the charity’s trustees<br>Signature(s)<br>Full name(s) Professor Pat Price<br>Position (e.g. Secretary, Chair<br>Chair, etc<br>Date 29.10.2021<br>**----- End of picture text -----**<br>




CHARIIY COMMISSION
FOR ENGLANO Ahlo WALE5
Receipts and
ments accounts
CC16a
For the ptriiod
from
To
Section A Receipts and payments
Endl￿￿7n&r￿t
lunds
fund4
rgt•l
L•si y
toth• r*V•M•t £ T•th•A•v••tE
t0th•a•￿Ile n•ar••t¢
Al Rfrcol
Con&￿On$
111.119
09
Sub tot•l(Gross *7com8 for
AR)
41,363
2 A88Qt and Inv•*tm¢ntMI•¥,
1$8* t•bl•
Sub total
Tot•1 rncelpts
111.119
111,IB
41,3fj3
AgP*
m•nls
r¢yMion Olvmtr￿1• rrnunk•lon¥
m•ai* UPd•t•
Lolln r•pa
Gern•r￿ idrfn co
IT & W•bsrt• hai
R&licther4py conts￿￿*t￿
Alp
50
1140
2.767
2.SJO
140
1717
7t2
¢0
4.•33
Sub totèi
4412
A4 Asset and Invoslmont
pur¢h4sts,
s¢e tsble
Sub total
592
Net of recwpts/(Pa￿entsJ
A5 Transferg bety¥o&n fvn•Js
A6 Cash funds last y•ar end
C8sh funds this year end
361
CCXX R1 accfAJnts (551
3010912021

Section B Statement of assets and Ilabilities at the end of the period
unre¥trlcted
nds
io n84rgs1£
Èndowment
fvnds
toTh•areBtE
thJnd¥
tj n•Ar•ste
B1 Ca8h fund8
99312
Toi*l tash funds
99212
Unmtrletsd
lunds
R•tstwl¢tod
fund8
Éndowm•nt
fuad
cuYNnt¥•iu•
D•lall•
CoBtIDpUoNII
B3 Inveutm¢nt a•••ts
Fundto¥yh*
•tb•
¢uir•nt¥ilu•
DotallB
B4 As8et• rotalnod for tho
charlty's Own UAe
Fund
du•
Oelp115
85 Liabiliti•$
21,872
Mrtrustee5
behsllof all Ihe irus
Dale of
&onatur8
Print Name
CCXX ￿ arrAiunls{SS)
3010912021

## **Independent Examiner's Report to the Trustees of ACORRN – Action Radiotherapy** 

I report to the trustees on my examination of the accounts of ACORRN – Action Radiotherapy for the year ended 22 June 2021. 

## **Responsibilities and basis of report** 

As the charity trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011. (‘the Act’). 

I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. 

## **Independent examiner’s statement** 

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

1. Accounting records were not kept in respect of the Trust as required by section 130 of the Act; or 

2. The accounts do not accord with those records. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report to enable a proper understanding of the accounts to be reached. 


Susan Redmond FCA DJH Mitten Clarke Manchester Limited Chartered Accountants St George's House 56 Peter Street Manchester M2 3NQ 

1 November 2021 



## **ACORRN – ACTION RADIOTHERAPY YEAR ENDED 22 JUNE 2021 NOTES TO ACCOUNTS** 

## **Interest-free loan** 

The charity received an interest-free loan from Price Jones Limited, a company in which one of the trustees Professor Patricia Price is a director and shareholder. The loan currently stands at £22,672 and is repayable at £2,500 per annum beginning 1 July 2017. 

## **Related party transactions** 

During the year there was a further £12,000 (2020: £9,333) paid to Price Jones Limited.  These were for general administrative costs, and costs relating to the All Party Parliamentary Group for Radiotherapy.  All transactions were considered to be at arm’s length. 

During the year donations of £61,680 were received from Radiotherapy4Life Limited, a company in which one of the trustees Patricia Price is a director and shareholder. 



## **Independent Examiner's Report to the Trustees of ACORRN – Action Radiotherapy** 

I report to the trustees on my examination of the accounts of ACORRN – Action Radiotherapy for the year ended 22 June 2021. 

## **Responsibilities and basis of report** 

As the charity trustees you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011. (‘the Act’). 

I report in respect of my examination of the Trust’s accounts carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act. 

## **Independent examiner’s statement** 

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

1. Accounting records were not kept in respect of the Trust as required by section 130 of the Act; or 

2. The accounts do not accord with those records. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report to enable a proper understanding of the accounts to be reached. 

See Accounts document for signed version 

Susan Redmond FCA Lloyd Piggott Limited Chartered Accountants St George's House 56 Peter Street Manchester M2 3NQ 

…………………….. 



## **ACORRN – ACTION RADIOTHERAPY YEAR ENDED 22 JUNE 2021 NOTES TO ACCOUNTS** 

## **Interest-free loan** 

The charity received an interest-free loan from Price Jones Limited, a company in which one of the trustees Professor Patricia Price is a director and shareholder. The loan currently stands at £22,672 and is repayable at £2,500 per annum beginning 1 July 2017. 

## **Related party transactions** 

During  the  year  there  was  a  further  £12,000  (2020:  £9,333)  paid  to  Price  Jones Limited.  These were for general administrative costs, and costs relating to the All Party Parliamentary Group for Radiotherapy.  All transactions were considered to be at arm’s length. 

During the year donations of £61,680 were received from Radiotherapy4Life Limited, a company in which one of the trustees Patricia Price is a director and shareholder. 

